echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Gen: Ten Trends of biomedicine in 2015

    Gen: Ten Trends of biomedicine in 2015

    • Last Update: 2015-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: ebootrade 2015-1-4 with the calendar of 2015 turning a new page, the biotechnology industry has entered a new year Gen website recently looked forward to the technology and market that are expected to grow rapidly in 2015, and summarized the top ten trends of the biological industry They believe that these technologies will become an important driving force for life science research and development, and help to promote biotechnology into new areas At the same time, M & A will continue to constitute the trend of financial and resource allocation, which is crucial to the development of the biological industry 1 Today, everyone is talking about the challenges of big data Biostatisticians and bioinformatics experts are solving problems and developing complex solutions to deal with massive amounts of information We can be sure that big data will become bigger in 2015 2 Biosimilars Frost & Sullivan predicts that the market size of biosimilars will increase from $1.2 billion in 2013 to $23 billion in 2019 As of mid November, the European Drug Administration (EMA) had approved more than 20 bio generics In July, the U.S FDA also accepted an application from Sandoz, Novartis's generics division More applications are expected in the US and Europe next year, and approvals are likely to be the same 3 Clinical genomics technology, new generation sequencing technology and biomarker research are gradually stepping out of research-based laboratory work and entering the stage of clinical application This stage has been set up as a medical practice based on genomics 4 Ebola and other emerging viruses, Ebola virus, have brought devastating blows to West Africa, and also sporadically appeared in the West Ebola may never disappear, and the mers, h7n9 and H5N1 viruses may also be potential killers With the rapid development of Ebola drugs, diagnosis and treatment companies have a huge opportunity to deal with these emerging viruses 5 Epigenetics for young scientists who are looking for a promising career, they should think about the research of epigenetics Closely linked to our genome, epigenetics is expected to have a market value of more than $783 million over the next five years They are expected to answer many genetic questions that cannot be answered by genes 6 Pfizer spent nearly 3 billion US dollars to reach an agreement with Merck in Germany to jointly develop PD ­ L1 antibody to treat a variety of cancers This is the latest in a series of deals aimed at developing drugs to help the immune system fight cancer 7 The report of M & A activity Burrill pointed out that in the first nine months of 2014, the transaction volume of life science M & A activity reached 231.5 billion US dollars, compared with 131.8 billion US dollars last year According to biopharm insight, as healthcare companies and institutions take into account the impact of affordable healthcare bills, economic recovery, and the need for capital and it improvements, many entities use mergers and acquisitions as a means to enhance their resources 8 Nanodrug nanodrug therapy allows a small amount of drugs to target specific parts of the body The aim of nanodrugs is to reduce costs, reduce side effects and treat diseases quickly 9 Personalized medicine is developing rapidly, which is characterized by the use of regenerative medicine, tissue engineering, stem cells, genomic medicine and pharmacogenomics Many experts believe that in the next 10 years, customized diagnosis and treatment for each patient will become part of daily medical practice 10 Synthetic biology Craig Venter and his colleagues are transforming pigs to grow human lungs for transplantation by changing their genetic code Synthetic biologists also use this technology in the development of biofuels, vaccines and antibodies, plants, industrial enzymes, and bio based chemicals  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.